286 related articles for article (PubMed ID: 7525924)
21. BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.
Weiser T; Brenner M; Palluk R; Bechtel WD; Ceci A; Brambilla A; Ensinger HA; Sagrada A; Wienrich M
J Pharmacol Exp Ther; 1999 Jun; 289(3):1343-9. PubMed ID: 10336525
[TBL] [Abstract][Full Text] [Related]
22. Studies of the antagonist actions of (RS)-2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl] propionic acid (ATPO) on non-NMDA receptors in cultured rat neurones.
Dai WM; Ebert B; Madsen U; Lambert JD
Br J Pharmacol; 1998 Dec; 125(7):1517-28. PubMed ID: 9884081
[TBL] [Abstract][Full Text] [Related]
23. Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655.
Szabados T; Gigler G; Gacsályi I; Gyertyán I; Lévay G
Brain Res Bull; 2001 Jun; 55(3):387-91. PubMed ID: 11489346
[TBL] [Abstract][Full Text] [Related]
24. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.
Yamaguchi S; Donevan SD; Rogawski MA
Epilepsy Res; 1993 Jul; 15(3):179-84. PubMed ID: 7693450
[TBL] [Abstract][Full Text] [Related]
25. Interactions of the dye Evans Blue and GYKI 52466, a 2,3-benzodiazepine, with (S)- alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured rat cortical neurons: electrophysiological evidence for at least two different binding sites for non-competitive antagonists.
Weiser T; Herrmann A; Wienrich M
Neurosci Lett; 1996 Sep; 216(1):29-32. PubMed ID: 8892384
[TBL] [Abstract][Full Text] [Related]
26. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
27. Sustained ethanol inhibition of native AMPA receptors on medial septum/diagonal band (MS/DB) neurons.
Frye GD; Fincher A
Br J Pharmacol; 2000 Jan; 129(1):87-94. PubMed ID: 10694206
[TBL] [Abstract][Full Text] [Related]
28. Role of desensitization and subunit expression for kainate receptor-mediated neurotoxicity in murine neocortical cultures.
Jensen JB; Schousboe A; Pickering DS
J Neurosci Res; 1999 Jan; 55(2):208-17. PubMed ID: 9972823
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors.
Gemignani A; Marchese S; Fontana G; Raiteri M
Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398
[TBL] [Abstract][Full Text] [Related]
30. AMPA-preferring receptors mediate excitatory synaptic inputs to retinal ganglion cells.
Lukasiewicz PD; Wilson JA; Lawrence JE
J Neurophysiol; 1997 Jan; 77(1):57-64. PubMed ID: 9120596
[TBL] [Abstract][Full Text] [Related]
31. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus.
Chittajallu R; Vignes M; Dev KK; Barnes JM; Collingridge GL; Henley JM
Nature; 1996 Jan; 379(6560):78-81. PubMed ID: 8538745
[TBL] [Abstract][Full Text] [Related]
32. Activation and desensitization of hippocampal kainate receptors.
Wilding TJ; Huettner JE
J Neurosci; 1997 Apr; 17(8):2713-21. PubMed ID: 9092592
[TBL] [Abstract][Full Text] [Related]
33. Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist.
Ruel J; Guitton MJ; Puell JL
CNS Drug Rev; 2002; 8(3):235-54. PubMed ID: 12353057
[TBL] [Abstract][Full Text] [Related]
34. Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.
May PC; Robison PM; Fuson KS
Neurosci Lett; 1999 Mar; 262(3):219-21. PubMed ID: 10218895
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones.
Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puja G; Baraldi M; De Micheli C
J Med Chem; 2000 Jul; 43(15):2851-9. PubMed ID: 10956193
[TBL] [Abstract][Full Text] [Related]
36. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.
Borowicz KK; Gasior M; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1995 Aug; 281(3):319-26. PubMed ID: 8521916
[TBL] [Abstract][Full Text] [Related]
37. Kainate receptor-mediated activation of the AP-1 transcription factor complex in cultured rat cerebellar granule cells.
Kovács AD; Cebers G; Liljequist S
Brain Res Bull; 2000 May; 52(2):127-33. PubMed ID: 10808083
[TBL] [Abstract][Full Text] [Related]
38. Desensitization of AMPA receptors on horizontal cells isolated from crucian carp retina.
Lu T; Shen Y; Yang XL
Neurosci Res; 1998 Jun; 31(2):123-35. PubMed ID: 9700718
[TBL] [Abstract][Full Text] [Related]
39. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
Ruiz A; Durand J
Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
[TBL] [Abstract][Full Text] [Related]
40. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
Donevan SD; Rogawski MA
Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
